In the hormone-independent PC3 prostate cancer cell line, melatonin was able to inhibit sphingosine kinase 1 (SPHK1) and the Akt/glycogen synthase kinase-3β signaling, therefore impairing the stimulation of HIF-1α [66]. This evidence concerns the gene SPHK1 and prostate carcinoma.